Abstract
Purpose
To compare mortality rates in glaucoma patients and matched controls from a large population screening as well as glaucoma patients diagnosed through routine clinical examination (self-selected patients).
Methods
A population-based screening of 32,918 elderly citizens of Malmö was conducted between 1992 and 1997. Individuals with newly detected, previously untreated open-angle glaucoma were identified. Two controls of the same age and gender were chosen among the screening negative participants for each patient. From the same birth cohorts, glaucoma patients seen in routine clinical practice (self-selected patients) were identified through retrospective examination of patient records from the Eye Department at Malmö University Hospital. The number and time of deaths for each group were determined based on centrally administered registers.
Results
Mean follow-up time was 7.75 years. Five-year mortality did not differ significantly between the groups, and was 9.2% among glaucoma patients from the screening (n=402), and 11.9% among the controls (n=804; p=0.7406). Self-selected glaucoma patients had a 5-year mortality of 8.5% (n=354), not significantly different from the screening-detected glaucoma patients (p=0.1361). Among glaucoma patients, neither IOP (p=0.1781) nor pseudoexfoliation (p=0.8882) was related to significantly increased mortality.
Conclusions
The results of this study strongly suggest that the life expectancy of glaucoma patients does not differ from the population at large.
Similar content being viewed by others
References
Anderson DR (1989) Glaucoma: the damage caused by pressure.XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108:485–495
Åsman P, Heijl A (1992a) Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 10:820–826
Åsman, Heijl A (1992b) Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 10:812–819
Bengtsson B (1984) Survival of elderly ophthalmic out-patients. Acta Ophthalmol Scand 62:725–730
Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003) Is there a direct association between age-related eye disease and mortality? Ophthalmology 110:1292–1296
Chung HS, Harris A, Evans DW et al. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43:S43–S50
Cox DR (1972) Regression models and life tables. J R Stat Soc B 30:187–202
Diggory P, Franks W (1996) Medical treatment of glaucoma: a reappraisal of the risks. Br J Ophthalmol 80:85–89
Drance SM, Sweeney VP, Morgan RW et al (1973) Studies of factors involved in the production of low-tension glaucoma. Arch Ophthalmol 89:457–465
Egge K, Zahl PH (1999) Survival of glaucoma patients. Acta Ophthalmol Scand 77:397–401
Flammer J, Gasser P, Prünte C et al. (1992) The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. Pharmacol Glaucoma 273–283
Grødum K, Heijl A, Bengtsson B (2002) A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthal Scand 80:627–631
Gupta N, Weinreib R (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41
Harrison R, Kaufmann CS (1977) Clonidine: effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95:1368–1373
Hayreh SS, Zimmerman BM, Podhajsky P et al. (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624
Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1278
Hennis A, Wu SY, Nemesure B et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908–914
Hietanen J, Soisalon-Soininen S, Kivela T et al. (2002) Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand 80:617–619
Hiller R, Podgor MJ, Sperduto RD et al. (1999) High introcular pressure and survival: the Framingham Studies. Am J Ophthalmol 128:440–445
Hodapp E, Kolker AE, Kass MA et al. (1981) The effect of topical clonidine on intraocular pressure. Arch Ophthalmol 99:1208–1211
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hyperrtension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713
Klein R, Klein BEK, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113:333–339
Lee DJ, Gómez-Marín O, Lam BL et al. (2003) Glaucoma and survival. The National Health Interview Survey 1986–1994. Ophthalmology 110:1476–1483
Leske C, Heijl A, Hyman L et al (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153
Leske MC (2003) Glaucoma and mortality: A connection? Guest editorial. Ophthalmology 110:1473–1475
Mitchell P, Smith W, Chey T et al. (1997) Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 104:712–718
Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687
Odberg T (1993) Visual field prognosis in early glaucoma: a long-term clinical follow-up. Acta Ophthalmol Scand 71:721–726
Odberg T, Jakobsen JE, Hultgren SJ et al. (2001) The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79:116–120
Repo L, Teräsvirta, Koivisto KJ (1993) Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100:352–355
Ringvold A, Blika S, Sandvik L (1997) Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 75:255–256
Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265–315
Schuman JS (2000) Antiglaucoma medications. A review of safety and tolerability issues related to their use. Clin Ther 22:167–208
Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86
Stewart WC, Osterman J (1998) Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 43:233–244
Thorburn W, Lindblom B (1983) Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol Scand 61:728–730
Tielsch Jm, Katz J, Sommer A et al. (1995) Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113:216–221
Wu SY, Nemesure B, Leske MC (2001) Observed versus indirect estimates of incidence of open-angle glaucoma. Am J Epidemiol 153:184–187
Acknowledgements
J. Olsson provided statistical advice. This study was supported by grants from the Swedish Research Council (K2002-74X-10426-10A), Malmö University Hospital, and the Järnhardt Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grødum, K., Heijl, A. & Bengtsson, B. Glaucoma and mortality. Graefe's Arch Clin Exp Ophthalmol 242, 397–401 (2004). https://doi.org/10.1007/s00417-004-0858-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-004-0858-2